The Impact of Substance Misuse During the COVID-19 Pandemic
This webcast discusses a number of topics pertaining to the substance use epidemic and updates in the use of naloxone especially during the COVID-19 pandemic.
This webcast discusses a number of topics pertaining to the substance use epidemic and updates in the use of naloxone especially during the coronavirus disease 2019 (COVID-19) pandemic. The panelists—Tyler Davis, PharmD, CVSHealth, Providence, Rhode Island; Jeffrey Bratberg, PharmD, FAPhA, URI College of Pharmacy, Providence, Rhode Island; and Amanda Glover, PharmD, Rite Aid, Camp Hill, Pennsylvania—discuss the importance of education and awareness of the availability of naloxone for patients and to remove the stigma of accidental overdoses. The recent update from the FDA requires that health care professional, when prescribing opioid pain medications, discuss the availability of naloxone with patients and care givers.
